Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
24-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #27305
advertisement
Chen YH
18
Showing records 1 to 18 |
Display all abstracts from
Chen YH
117712
A highly sensitive fluorescent probe RN-NA reveals peroxynitrite as a novel biomarker for primary open angle glaucoma
Qin B
International Journal of Ophthalmology
2024; 17: 219-227
116771
Identification of a circulating three-miRNA panel for the diagnosis of primary open angle glaucoma
Qin B
International Ophthalmology
2024; 44: 176
118503
ADSC-Exos outperform BMSC-Exos in alleviating hydrostatic pressure-induced injury to retinal ganglion cells by upregulating nerve growth factors
Zheng ZK
World journal of stem cells
2023; 15: 1077-1092
116828
The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Feng KM
Cells
2023; 12:
116771
Identification of a circulating three-miRNA panel for the diagnosis of primary open angle glaucoma
Li LP
International Ophthalmology
2024; 44: 176
118503
ADSC-Exos outperform BMSC-Exos in alleviating hydrostatic pressure-induced injury to retinal ganglion cells by upregulating nerve growth factors
Kong L
World journal of stem cells
2023; 15: 1077-1092
116828
The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Tsung TH
Cells
2023; 12:
117712
A highly sensitive fluorescent probe RN-NA reveals peroxynitrite as a novel biomarker for primary open angle glaucoma
Lei Y; Bao L
International Journal of Ophthalmology
2024; 17: 219-227
116828
The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Chen YH
Cells
2023; 12:
118503
ADSC-Exos outperform BMSC-Exos in alleviating hydrostatic pressure-induced injury to retinal ganglion cells by upregulating nerve growth factors
Dai M
World journal of stem cells
2023; 15: 1077-1092
116771
Identification of a circulating three-miRNA panel for the diagnosis of primary open angle glaucoma
Xu QD
International Ophthalmology
2024; 44: 176
118503
ADSC-Exos outperform BMSC-Exos in alleviating hydrostatic pressure-induced injury to retinal ganglion cells by upregulating nerve growth factors
Chen YD
World journal of stem cells
2023; 15: 1077-1092
117712
A highly sensitive fluorescent probe RN-NA reveals peroxynitrite as a novel biomarker for primary open angle glaucoma
Zhang YJ
International Journal of Ophthalmology
2024; 17: 219-227
116771
Identification of a circulating three-miRNA panel for the diagnosis of primary open angle glaucoma
Lei Y
International Ophthalmology
2024; 44: 176
116828
The Role of Retinal Ganglion Cell Structure and Function in Glaucoma
Lu DW
Cells
2023; 12:
116771
Identification of a circulating three-miRNA panel for the diagnosis of primary open angle glaucoma
Chen YH
International Ophthalmology
2024; 44: 176
118503
ADSC-Exos outperform BMSC-Exos in alleviating hydrostatic pressure-induced injury to retinal ganglion cells by upregulating nerve growth factors
Chen YH
World journal of stem cells
2023; 15: 1077-1092
117712
A highly sensitive fluorescent probe RN-NA reveals peroxynitrite as a novel biomarker for primary open angle glaucoma
Liu KY; Chen YH
International Journal of Ophthalmology
2024; 17: 219-227
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept